Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Anderson

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.
Clinical Chemistry and Laboratory Medicine|February 17, 2023
Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassayPhilip M Hemken, Eitan Israeli, Russell Taylor, et al.
MMWR. Morbidity and Mortality Weekly Report|August 28, 2020
COVID-19 Among American Indian and Alaska Native Persons - 23 States, January 31-July 3, 2020Sarah M Hatcher, Christine Agnew-Brune, Mark Anderson, et al.
MMWR. Morbidity and Mortality Weekly Report|October 1, 2020
CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020Emilio Dirlikov, Ethan Fechter-Leggett, Stacy L Thorne, et al.
MMWR. Morbidity and Mortality Weekly Report|May 16, 2024
U.S. Preparedness and Response to Increasing Clade I Mpox Cases in the Democratic Republic of the Congo - United States, 2024Jennifer H McQuiston, Richard Luce, Dieudonne Mwamba Kazadi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 2, 2025
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionMary A Rodgers, Francisco Averhoff, Michael G Berg, et al.
Journal of Clinical Microbiology|October 27, 2021
Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020Olivia Almendares, Jessica L Prince-Guerra, Leisha D Nolen, et al.
Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2022
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complicationsAaron Bodansky, Sara E Vazquez, Janet Chou, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.
Clinical Chemistry and Laboratory Medicine|February 17, 2023
Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassayPhilip M Hemken, Eitan Israeli, Russell Taylor, et al.
MMWR. Morbidity and Mortality Weekly Report|August 28, 2020
COVID-19 Among American Indian and Alaska Native Persons - 23 States, January 31-July 3, 2020Sarah M Hatcher, Christine Agnew-Brune, Mark Anderson, et al.
MMWR. Morbidity and Mortality Weekly Report|October 1, 2020
CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020Emilio Dirlikov, Ethan Fechter-Leggett, Stacy L Thorne, et al.
MMWR. Morbidity and Mortality Weekly Report|May 16, 2024
U.S. Preparedness and Response to Increasing Clade I Mpox Cases in the Democratic Republic of the Congo - United States, 2024Jennifer H McQuiston, Richard Luce, Dieudonne Mwamba Kazadi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 2, 2025
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionMary A Rodgers, Francisco Averhoff, Michael G Berg, et al.
Journal of Clinical Microbiology|October 27, 2021
Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020Olivia Almendares, Jessica L Prince-Guerra, Leisha D Nolen, et al.
Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2022
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complicationsAaron Bodansky, Sara E Vazquez, Janet Chou, et al.
Pageof 38